The Lady Davis Institute for Medical Research (LDI) offers outstanding training opportunities for postdoctoral fellows, clinical research fellows, graduate and undergraduate students in partnership with McGill University. Join us at the LDI! Below is the list of trainee opportunities currently available at the LDI. This list is updated regularly, so please check back often.
The LDI is committed to equity, diversity and inclusion within its community. The LDI has an equal opportunity employment program and welcomes applications from all qualified candidates, regardless of their characteristics, with the skills and knowledge to productively engage with diverse communities. Accommodation for any part of the application process may be provided to persons with disabilities who request it.
Department:
BC Children’s Hospital Research Institute
Supervisors:
Dr. Wazana is a Child Psychiatrist, Associate Professor, Department of Psychiatry and Director, Early Childhood Disorders psychiatric day hospital, Jewish General Hospital, studying pre- and perinatal influences on lifetime psychopathology.
Dr. Oberlander is a Developmental Pediatrician, Professor, Dept of Pediatrics and School of Population and Public Health, studying how early experiences influence child development.
Dr. Laplante is a research scientist with expertise in perinatal impacts (disasters, maternal mood, socio-environmental) on development across the lifespan.
Project description:
A collaboration between the Lady Davis Institute for Medical Research (LDI: Montreal, Quebec) and the BC Children’s Hospital Research Institute (BCCHR: Vancouver, British Columbia) is now accepting applications for the 2022 Webster Postdoctoral Scholars Program to support exceptional research trainees and generate innovative research in Child Development and Neuroscience under the mentorship of Drs. Ashley Wazana (McGill University) and Tim Oberlander (university of British Columbia) in the area of developmental neuroscience. The postdoctoral scholar will also work closely with Drs. David P Laplante and François Freddy Ateba (LDI) in onboarding the rich UBC longitudinal dataset, Pregnancy during the COVID-19 Pandemic study, into the Developmental Research in Early Adversity Mental Health BIological Susceptibility and Gender (DREAM BIG) consortium of perinatal longitudinal birth cohorts, focusing on the harmonization and analysis of the UBC perinatal maternal adversity and child mental health outcomes from the so that comparable analyses can be performed across the DREAM BIG cohorts in an effort to increase replication of mental health findings that can inform treatment and public policy.
The goal of the program is to support recent a PhD or MD graduate in conducting clinical and translational research with the intent to develop future leaders in Child Developmental Health research.
Applicants should have training in neuroscience, psychology, medical sciences (Pediatrics), or other relevant discipline, and experience with MR image acquisition, processing, and/or analysis.
Interested candidates should submit a letter of interest, CV, graduate transcript(s), and names and contact information for at least two references to Dr. Tim Oberlander (email: toberlander@bcchr.ca).
Department:
Lady Davis Institute for Medical Research, Jewish General Hospital.
Supervisor:
Mark Trifiro, MD, professor in the Division of Experimental Medicine at McGill University and senior researcher at the Lady Davis Institute for Medical Research of the Jewish General Hospital.
Project description:
MITACS funds are available for the recruitment for a post-doctoral fellow, that will oversee large scale efficacy of targeted multi-walled carbon nanotubes for the photothermal ablation of xenograft prostate cancer tumors.
As part of our route towards development of the technology for clinical applicability as a photothermal treatment for prostate cancer (PCa), we will be determining the efficacy of our Glu-urea-Lys-MWCNT nanoformulation platform by assessing tumor recurrence and disease-free outcomes The Glu-urea-Lys-MWCNT formulation uses a peptidomimetic compound that binds to the Prostate Specific Membrane Antigen (PSMA); a PCa-specific surface receptor whose expression is correlated with disease onset and progression.
Simultaneously, tests will also be performed to assess photothermal therapy safety of the nanoformulation, biochemical blood testing, histopathological analysis and. adverse events will be documented.
Interested candidates are invited to submit a CV and cover letter by email to Dr. Mark Trifiro at: mark.trifiro@mcgill.ca and Dr. Miltiadis Paliouras at mpaliouras@guzzonanoresearch.ca.
Note: This position is supported by MITACS award.
Department:
Department of Psychiatry, Jewish General Hospital and McGill University.
Supervisors:
Danielle Groleau, PhD, full professor in the Division of Social and Transcultural Psychiatry at McGill University and senior researcher at the Lady Davis Institute for Medical Research of the Jewish General Hospital
Project description:
The postnatal period represents a challenge for many mothers, making them vulnerable to psychiatric disorders, particularly depressive episodes. Maternal PND can have adverse effects on both mother and infant, often leading to early weaning. Conversely, successful breastfeeding has been associated with an improvement in PND symptoms. Despite this, the underlying mechanisms of the relationship between PND and breastfeeding remain poorly understood. This study aims to fill this gap by focusing on cultural communities such as Orthodox and Hasidic Jewish as well as South Saharan African women, where breastfeeding despite DPN is much more prevalent.
Interested candidates should submit a cover letter, curriculum vitae, a brief (1-page) statement of research interests and career goals, and contact information for five references. Please send your application to psychosocial.ccomtl@ssss.gouv.qc.ca with the subject line “Application Postdoctoral Fellow – [Your Name]”. Applications will be considered until the position is filled.
Note: This postdoctoral fellowship is conditional on obtaining a UTTING fellowship from the Department of Psychiatry at the Jewish General Hospital.
Department:
Department of Oncology, McGill University
Jewish General Hospital (JGH) and Lady Davis Institute for Medical Research (LDI)
Supervisors:
Dr. Melica Brodeur, MSc, MD, Assistant Professor, Department of Obstetrics and Gynecology, McGill University
Project description:
The MSc or PhD student will contribute to the design, execution, and analysis of translational research projects aimed at improving precision oncology in gynecological cancers. This role will involve a combination of wet lab (preclinical studies, cell culture, animal models) and dry lab (cancer genomics and pathology) research. The graduate student will gain valuable experience in conducting biomedical research, data analysis, and scientific communication.
Candidates should either hold a Bachelor’s or Master’s degree, or be willing to start in a Masters program (students can transfer to PhD before completing the MSc), and have strong wet lab skills, including cell culture, DNA/RNA/protein isolation, Western blotting, immunostaining, etc. (preferably with hands-on training for recent Master’s graduates, but also open to candidates with foundational knowledge who are eager to pursue a Master’s).
Interested candidates should send their curriculum vitae, transcript and a cover letter explaining your research interests, career goals, and how you meet the qualifications for this position to: melica.brodeur@mcgill.ca.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
